Stockreport

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug [Yahoo! Finance]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF and immune-related diseases, today announced that Health Canada has approved the company's proposal to harmonize clinical trial designs in the U.S. and Canada for an ong [Read more]